Actively Recruiting
Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
Led by Lille Catholic University · Updated on 2024-05-07
60
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
Sponsors
L
Lille Catholic University
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the study is to evaluate chemogram in patients with intermediate-grade superficial bladder cancer and patients with infiltrating bladder cancer, who are likely to be treated according to the standard procedure. This project is based on the premise that treatments - notably chemotherapy - are standard, but that each cancer is unique. It is therefore necessary to personalize the treatment for each patient, while at the same time proposing an approach that is economically bearable for the healthcare system. For both types of bladder tumor, chemotherapy is used either as an alternative to immunotherapy, or as an adjuvant to surgery. Its use is therefore based on its effectiveness in reducing post-treatment recurrence.
CONDITIONS
Official Title
Prognostic Performance of a Chemogram in Patients With Bladder Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient
- Patient with suspected bladder cancer likely to be treated with chemotherapy
- Patient affiliated to a social security scheme
You will not qualify if you...
- Insufficient tumor volume
- Patient under guardianship
- Pregnant or breast-feeding women
- Patient opposed to participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital St Philibert
Lomme, France, 59160
Actively Recruiting
Research Team
M
Marie-Paule Lebitasy
CONTACT
B
Berenice MARCHANT
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here